83 related articles for article (PubMed ID: 309398)
1. Studies on induction and control of cell-mediated autoimmunity. I. Induction of "autoreactive" T lymphocytes in mice by cyclophosphamide.
L'age-Stehr J; Diamantstein T
Eur J Immunol; 1978 Sep; 8(9):620-4. PubMed ID: 309398
[TBL] [Abstract][Full Text] [Related]
2. Studies on induction and control of cell-mediated autoimmunity. II. Prevention of induction and activity of autoreactive T cells by suppressor cells and by a suppressive serum factor.
L'age-Stehr J; Diamantstein T
Eur J Immunol; 1978 Sep; 8(9):624-8. PubMed ID: 309399
[TBL] [Abstract][Full Text] [Related]
3. The influence of cyclophosphamide on antibody formation in the mouse.
Willers JM; Sluis E
Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
Ye QW; Mokyr MB
Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
[TBL] [Abstract][Full Text] [Related]
5. Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice.
Gill HK; Liew FY
Eur J Immunol; 1978 Mar; 8(3):172-6. PubMed ID: 306925
[TBL] [Abstract][Full Text] [Related]
6. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
Sihvola M; Hurme M
J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
[TBL] [Abstract][Full Text] [Related]
7. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
Wander RH; Hilgard HR
J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.
Awwad M; North RJ
Cancer Res; 1989 Apr; 49(7):1649-54. PubMed ID: 2522344
[TBL] [Abstract][Full Text] [Related]
9. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
Mokyr MB; Ye QW
Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
[TBL] [Abstract][Full Text] [Related]
10. Activation of type III pneumococcal polysaccharide-specific suppressor T cells in cyclophosphamide-treated mice requirement for recognition of antigen and I-J determinants on antigen coupled to syngeneic spleen cells.
Braley-Mullen H
J Immunol; 1983 Nov; 131(5):2190-5. PubMed ID: 6195257
[TBL] [Abstract][Full Text] [Related]
11. Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytoma.
Nio Y; Ohgaki K; Tobe T
J Clin Lab Immunol; 1989 May; 29(1):37-43. PubMed ID: 2534133
[TBL] [Abstract][Full Text] [Related]
12. A role of L3T4+ antigen in the Con A response of regenerating splenic L3T4+ T cells after Cy treatment.
Ikezawa Z; Sato M; Aoki I
Immunology; 1987 Mar; 60(3):375-82. PubMed ID: 3106196
[TBL] [Abstract][Full Text] [Related]
13. High-dose cyclophosphamide inhibits anterior chamber-associated immune deviation (ACAID) and the production of extracellular antigen-specific T cell proteins induced by trinitrophenylated (TNP) spleen cells.
Wang Y; O'Rourke J; Cone RE
Cell Immunol; 1995 Oct; 165(2):284-8. PubMed ID: 7553893
[TBL] [Abstract][Full Text] [Related]
14. Splenic modifications induced by cyclophosphamide in C3H/He, nude, and "B" mice.
Kolb JP; Poupon MF; Lespinats GM; Sabolovic D; Loisillier F
J Immunol; 1977 May; 118(5):1595-9. PubMed ID: 300749
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclophosphamide on spleen cell suppressor activity and tumour growth in mice.
Larsen FS; Spärck JV
Acta Pathol Microbiol Immunol Scand C; 1983 Oct; 91(5):323-33. PubMed ID: 6229132
[TBL] [Abstract][Full Text] [Related]
16. Induction of suppressor cells in mice by cyclophosphamide.
Poupon MF; Kolb JP; Lespinats G
Ann Immunol (Paris); 1978; 129 C(4):475-87. PubMed ID: 697315
[TBL] [Abstract][Full Text] [Related]
17. The effect of cyclophosphamide on cytotoxic T-lymphocyte responses: inhibition of helper T-cell induction in vitro.
Varkila K; Hurme M
Immunology; 1983 Mar; 48(3):433-8. PubMed ID: 6219062
[TBL] [Abstract][Full Text] [Related]
18. The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance.
Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K
Eur J Immunol; 1990 Sep; 20(9):2005-13. PubMed ID: 2209702
[TBL] [Abstract][Full Text] [Related]
19. The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro.
Shand FL
Immunology; 1978 Dec; 35(6):1017-25. PubMed ID: 33118
[TBL] [Abstract][Full Text] [Related]
20. 4-hydroperoxy-cyclophosphamide mediates caspase-independent T-cell apoptosis involving oxidative stress-induced nuclear relocation of mitochondrial apoptogenic factors AIF and EndoG.
Strauss G; Westhoff MA; Fischer-Posovszky P; Fulda S; Schanbacher M; Eckhoff SM; Stahnke K; Vahsen N; Kroemer G; Debatin KM
Cell Death Differ; 2008 Feb; 15(2):332-43. PubMed ID: 18034189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
